Lenka Hromádková

510 total citations
20 papers, 389 citations indexed

About

Lenka Hromádková is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, Lenka Hromádková has authored 20 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Physiology and 5 papers in Neurology. Recurrent topics in Lenka Hromádková's work include Alzheimer's disease research and treatments (9 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Prion Diseases and Protein Misfolding (3 papers). Lenka Hromádková is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Prion Diseases and Protein Misfolding (3 papers). Lenka Hromádková collaborates with scholars based in Czechia, United States and United Kingdom. Lenka Hromádková's co-authors include Lars O. Tjernberg, Sophia Schedin‐Weiss, Anna Matton, Bengt Winblad, Susanne Frykman, Mitsuhiro Inoue, Nenad Bogdanović, Birgitta Wiehager, Yasuhiro Teranishi and Saak V. Ovsepian and has published in prestigious journals such as Science Translational Medicine, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research and The Analyst.

In The Last Decade

Lenka Hromádková

20 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lenka Hromádková Czechia 10 162 156 128 69 52 20 389
Hossein Ashrafian Iran 9 169 1.0× 122 0.8× 66 0.5× 40 0.6× 55 1.1× 10 408
Paulo Roberto Louzada Brazil 9 245 1.5× 183 1.2× 62 0.5× 131 1.9× 50 1.0× 14 507
Xinchao Hu China 8 144 0.9× 121 0.8× 72 0.6× 53 0.8× 57 1.1× 10 358
Yilin Xia China 5 140 0.9× 130 0.8× 89 0.7× 52 0.8× 62 1.2× 12 417
Julie Paquette Canada 8 358 2.2× 148 0.9× 164 1.3× 73 1.1× 88 1.7× 10 541
María Ximena Silveyra Spain 11 122 0.8× 161 1.0× 130 1.0× 37 0.5× 25 0.5× 16 362
Alex L. Lublin United States 12 316 2.0× 275 1.8× 100 0.8× 74 1.1× 54 1.0× 18 658
Simon Heales United Kingdom 6 220 1.4× 177 1.1× 35 0.3× 50 0.7× 53 1.0× 8 416
Seungyeop Baek South Korea 7 171 1.1× 121 0.8× 59 0.5× 43 0.6× 41 0.8× 12 303

Countries citing papers authored by Lenka Hromádková

Since Specialization
Citations

This map shows the geographic impact of Lenka Hromádková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lenka Hromádková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lenka Hromádková more than expected).

Fields of papers citing papers by Lenka Hromádková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lenka Hromádková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lenka Hromádková. The network helps show where Lenka Hromádková may publish in the future.

Co-authorship network of co-authors of Lenka Hromádková

This figure shows the co-authorship network connecting the top 25 collaborators of Lenka Hromádková. A scholar is included among the top collaborators of Lenka Hromádková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lenka Hromádková. Lenka Hromádková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hromádková, Lenka, Chae Kim, Tracy Haldiman, et al.. (2023). Evolving prion-like tau conformers differentially alter postsynaptic proteins in neurons inoculated with distinct isolates of Alzheimer’s disease tau. Cell & Bioscience. 13(1). 174–174. 2 indexed citations
2.
Kim, Chae, Tracy Haldiman, Lenka Hromádková, et al.. (2022). Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer’s disease. Science Translational Medicine. 14(626). eabg0253–eabg0253. 33 indexed citations
3.
Hromádková, Lenka, Mohammad Khursheed Siddiqi, He Liu, & Jiri Safar. (2022). Populations of Tau Conformers Drive Prion-like Strain Effects in Alzheimer’s Disease and Related Dementias. Cells. 11(19). 2997–2997. 10 indexed citations
4.
Hromádková, Lenka, et al.. (2020). Brain-derived neurotrophic factor (BDNF) promotes molecular polarization and differentiation of immature neuroblastoma cells into definitive neurons. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(9). 118737–118737. 48 indexed citations
5.
Špringer, Tomáš, Jan Říčný, Lenka Hromádková, et al.. (2020). Interactions of 17β-Hydroxysteroid Dehydrogenase Type 10 and Cyclophilin D in Alzheimer's Disease. Neurochemical Research. 45(4). 915–927. 6 indexed citations
6.
Eskandari‐Sedighi, Ghazaleh, et al.. (2020). Cellular Biology of Tau Diversity and Pathogenic Conformers. Frontiers in Neurology. 11. 590199–590199. 17 indexed citations
7.
Hromádková, Lenka & Saak V. Ovsepian. (2019). Tau-Reactive Endogenous Antibodies: Origin, Functionality, and Implications for the Pathophysiology of Alzheimer’s Disease. Journal of Immunology Research. 2019. 1–11. 13 indexed citations
8.
9.
Hromádková, Lenka, et al.. (2017). Purification of Natural Antibodies Against Tau Protein by Affinity Chromatography. Methods in molecular biology. 1643. 33–44. 3 indexed citations
10.
Schedin‐Weiss, Sophia, Mitsuhiro Inoue, Lenka Hromádková, et al.. (2017). Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels. Alzheimer s Research & Therapy. 9(1). 57–57. 179 indexed citations
11.
Hromádková, Lenka, et al.. (2017). Kinase-loaded magnetic beads for sequentialin vitrophosphorylation of peptides and proteins. The Analyst. 143(2). 466–474. 9 indexed citations
12.
Hromádková, Lenka, et al.. (2015). Difficulties associated with the structural analysis of proteins susceptible to form aggregates: The case of Tau protein as a biomarker of Alzheimer's disease. Journal of Separation Science. 39(4). 799–807. 3 indexed citations
13.
Hromádková, Lenka, Michala Kolarova, Aleš Bartoš, et al.. (2015). Identification and characterization of natural antibodies against tau protein in an intravenous immunoglobulin product. Journal of Neuroimmunology. 289. 121–129. 14 indexed citations
15.
Hromádková, Lenka, et al.. (2014). Quality evaluation of monoclonal antibodies suitable for immunomagnetic purification of native tau protein. Digitální knihovna Univerzity Pardubice (Univerzity Pardubice). 1 indexed citations
16.
Hromádková, Lenka, et al.. (1981). [Hyperbilirubinemia and phototherapy in low birth weight newborn infants].. PubMed. 36(10). 561–5. 1 indexed citations
17.
Miler, I, et al.. (1981). Bilirubin inhibits the chemotactic activity of human polymorphonuclear leukocytesin vitro. Folia Microbiologica. 26(5). 413–416. 16 indexed citations
18.
Miler, I, Jan Vondráček, & Lenka Hromádková. (1979). The bactericidal activity of sera of healthy neonates and of newborns with hyperbilirubinaemia toEscherichia coli. Folia Microbiologica. 24(2). 143–152. 19 indexed citations
19.
Miler, I, et al.. (1979). Skin-window study on the migration of leukocytes of newborns and infants. Folia Microbiologica. 24(5). 408–414. 1 indexed citations
20.
Hromádková, Lenka, et al.. (1963). [ANTIBODY LEVEL AGAINST ENDOGENOUS STRAINS OF E. COLI FROM BIRTH TO 1 YEAR OF AGE].. PubMed. 18. 613–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026